Atlas Trials

Nir Peled

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Nir Peled

RecordFirmDate
First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy (NCT06667167)Nir Peled2024-12-24
A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC (NCT05698264)Nir Peled2023-01-20

Track Nir Peled automatically

Every clearance here is in the API, with alerts when new ones post.